Furthermore, in human MDA‐MB‐231 and MCF‐7 breast cancer cells, as well as Kapras299 and L428 lymphoma cells, TNFR2 expression promotes the growth of tumor cells and protects malignant cells from DNA damage caused by chemotherapeutic agent adriamycin18,19. Here, TNFRSF1B is linked to breast carcinoma.